DEFINITIVE PROXY STATEMENT

Company

Centessa Pharmaceuticals plc

Filed

May 15, 2023

Period of Report

June 22, 2023

Accession Number

0001387131-23-006494

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →